参考文献(上下滑动查看)
[1] Leslie RD, Ma RCW, Franks PW, Nadeau KJ, Pearson ER, Redondo MJ.
Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes.
Lancet Diabetes Endocrinol 2023; 11: 848–60.
[2] Leslie RD, Evans-Molina C, Freund-Brown J, et al.
Adult-onset type 1 diabetes: current understanding and challenges.
Diabetes Care 2021; 44: 2449–56.
[3] Redondo MJ, Morgan NG.
Heterogeneity and endotypes in type 1 diabetes mellitus.
Nat Rev Endocrinol 2023; 19: 542–54.
[4] Ziegler AG.
The countdown to type 1 diabetes: when, how and why does the clock start?
Diabetologia 2023; 66: 1169–78.
[5] Lernmark Å.
Etiology of autoimmune islet disease: timing is everything.
Diabetes 2021; 70: 1431–39.
[6] Redondo MJ, Yu L, Hawa M, et al.
Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States.
Diabetologia 2001; 44: 354–62.
[7] Inshaw JRJ, Cutler AJ, Crouch DJM, Wicker LS, Todd JA.
Genetic variants predisposing most strongly to type 1 diabetes diagnosed under age 7 years lie near candidate genes that function in the immune system and in pancreatic β-cells.
Diabetes Care 2020; 43: 169–77.
[8] Wei Y, Liu S, Andersson T, Feychting M, Kuja-Halkola R, Carlsson S.
Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a genetically informative register-based cohort study.
Lancet Diabetes Endocrinol 2024; published online March 29.
https://doi.org/10.1016/S2213-8587(24)00068-8.
[9] Taylor PN, Collins KS, Lam A, et al.
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.
Lancet Diabetes Endocrinol 2023; 11: 915–25.
[10] Allen LA, Taylor PN, Gillespie KM, Oram RA, Dayan CM.
Maternal type 1 diabetes and relative protection against offspring transmission.
Lancet Diabetes Endocrinol 2023; 11: 755–6